XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.3Close
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
Premiums $ 30,925 $ 24,657 $ 91,983 $ 74,117
Net investment income 550 277 1,398 885
Total revenues 95,428 89,764 275,099 263,963 CloseClose
Operating costs:        
Cost of products sold 52,948 54,688 151,019 159,679
Health care costs 29,922 21,499 85,578 63,729
Operating expenses 10,557 9,876 31,185 29,329
Restructuring charges 1,169 11 1,169 507
Loss on assets held for sale 0 0 0 349
Total operating costs 94,596 86,074 268,951 253,593 CloseClose
Operating income 832 3,690 6,148 10,370 CloseClose
Interest expense 752 693 2,200 1,968 Close
Other income (25) (22) (74) (66) CloseCloseClose
Total Other Income Expenses 727.0 671.0 2126.0 1902.0 0.0 Close
Income before income tax provision 105 3,019 4,022 8,468 CloseCloseClose
Income tax provision 34 754 1,059 2,147 CloseClose
Net income 71 2,265 2,963 6,321 CloseClose
Net (income) loss attributable to noncontrolling interests 16 (4) 7 (23)
Net income attributable to CVS Health $ 87 $ 2,261 $ 2,970 $ 6,298
Net income per share attributable to CVS Health:        
Basic (in dollars per share) $ 0.07 $ 1.76 $ 2.36 $ 4.90
Diluted (in dollars per share) $ 0.07 $ 1.75 $ 2.35 $ 4.88
Weighted average shares outstanding:        
Basic (in shares) 1,259 1,287 1,258 1,284
Diluted (in shares) 1,259 1,290 1,262 1,289
Dividends declared per share (in dollars per share) $ 0.665 $ 0.605 $ 1.995 $ 1.815
Cost, Product and Service [Extensible List] Products Products Products Products
Products        
Revenues:        
Revenues $ 59,674 $ 61,298 $ 169,610 $ 179,984
Services        
Revenues:        
Revenues $ 4,279 $ 3,532 $ 12,108 $ 8,977